Lonza Swipes a Top Roche Executive to Be Its Next CEO
The current head of global pharma technical operations at Roche (OTC: RHHBY) is jumping ship to take the lead role at Lonza (OTC: LZAGY). Pierre-Alain Ruffieux will become the new chief executive officer of the contract development and manufacturing organization on Nov. 1.
Ruffieux has the extensive biopharmaceutical experience that Lonza's board of directors was looking for. Prior to managing a team of 12,000 at Roche, he worked for the other Swiss drug-making giant, Novartis, and has more than 20 years of industry experience.
Image source: Getty Images.
Source Fool.com
